Orchid Pharma Shares Go Up 14,277%; then Crash 70%

  • Investing.com
  • Stock Market News
Orchid Pharma Shares Go Up 14,277%; then Crash 70%

By Aditya Raghunath

Investing.com -- Orchid Pharma Ltd (NS: ORCD )’s share price trajectory since it got relisted in November is a classic example of retail investors getting caught with shares that are very difficult to exit.

Orchid Pharma went through the NCLT (National Company Law Tribunal) last year and was acquired by Dhanuka Labs who owned over 98% of the company. The company relisted on the stock exchanges on November 3, 2020 at Rs 18 a share.

The next five months saw the stock zoom up over 14,277% to Rs 2,588.4 on April 1, 2021. Since then, the stock has lost over 69% of its value and is currently trading at Rs 786.05. When the stock falls, it gets locked into a lower circuit of 5%.

NSE data shows that between November 3 and April 5, not a single share of Orchid Pharma was taken in delivery.

On June 24, 2021, Dhanuka Labs announced an offer-for-sale (OFS) for Orchid Pharma shares at Rs 375 a share. The OFS finally went through at Rs 451 a share. Clearly, no one thinks that Orchid shares are worth more than that. The shares will likely fall further according to market experts.

According to Securities and Exchange Board of India rules, promoters need to ensure that at least 10% of a company’s holding is with the public, which means Dhanuka will have to get their holding down to 90%.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

  • anuj nanwani @anuj nanwani
    promoter holding should be less than or equal to 75%
    Like 1
  • arvind bhalsod @arvind bhalsod
    Great sir
    Like 2

Related Articles